- Chemicals for Life Science -

Enasidenib Mesylate

Cat. No.: DC44726 Featured

Chemical Structure

1650550-25-6

For research use only. We do not sell to patients.

We match the best price and quality on market.
Email:order@dcchemicals.com sales@dcchemicals.com
Tel:+86-021-58447131

We are official vendor of:

More than 5000 active chemicals with high quality for research!

Field of application

Enasidenib (Idhifa, AG-221) mesylate is an orally available, selective and potent inhibitor of mutant isocitrate dehydrogenase 2 (IDH2).

Cas No.:	1650550-25-6
Chemical Name:	Enasidenib\xa0mesylate
Synonyms:	Enasidenib mesylate;AG-221 mesylate
SMILES:	CS(=O)(O)=O.CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1
Formula:	C₂₀H₂₁F₆N₇O₄S
M.Wt:	569.480663061142
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

TITLE	DOWNLOAD
MSDS_28432_DC44726_1650550-25-6

COA

LOT NO.	DOWNLOAD

Cat. No.	Product name	Field of application
DC44726	Enasidenib Mesylate	Enasidenib (Idhifa, AG-221) mesylate is an orally available, selective and potent inhibitor of mutant isocitrate dehydrogenase 2 (IDH2).
DC28576	DS-1001b	DS-1001b is a mutant IDH-1 (Isocitrate Dehydrogenase-1) inhibitor extracted from patent WO2016052697A1, Example 168, and has antitumor activity.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.